Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2008 1
2010 1
2011 2
2012 3
2013 2
2014 2
2015 7
2016 2
2017 3
2018 4
2019 2
2020 2
2021 4
2022 5
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Cytosporone B is an agonist for nuclear orphan receptor Nur77.
Zhan Y, Du X, Chen H, Liu J, Zhao B, Huang D, Li G, Xu Q, Zhang M, Weimer BC, Chen D, Cheng Z, Zhang L, Li Q, Li S, Zheng Z, Song S, Huang Y, Ye Z, Su W, Lin SC, Shen Y, Wu Q. Zhan Y, et al. Among authors: song s. Nat Chem Biol. 2008 Sep;4(9):548-56. doi: 10.1038/nchembio.106. Nat Chem Biol. 2008. PMID: 18690216 Free article.
Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines.
Cheng Y, Song S, Wu P, Lyu B, Qin M, Sun Y, Sun A, Mu L, Xu F, Zhang L, Wang J, Zhang Q. Cheng Y, et al. Among authors: song s. Adv Healthc Mater. 2021 Sep;10(18):e2100590. doi: 10.1002/adhm.202100590. Epub 2021 Jul 22. Adv Healthc Mater. 2021. PMID: 34292673 Review.
A new ALK inhibitor overcomes resistance to first- and second-generation inhibitors in NSCLC.
Lu Y, Fan Z, Zhu SJ, Huang X, Zhuang Z, Li Y, Deng Z, Gao L, Hong X, Zhang T, Li L, Sun X, Huang W, Zhang J, Liu Y, Zhang B, Jiang J, Gui F, Wang Z, Li Q, Song S, Huang X, Wu Q, Chen L, Zhou D, Zhang J, Yun CH, Chen L, Deng X. Lu Y, et al. Among authors: song s. EMBO Mol Med. 2022 Jan 11;14(1):e14296. doi: 10.15252/emmm.202114296. Epub 2021 Nov 30. EMBO Mol Med. 2022. PMID: 34845836 Free PMC article.
Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.
Jiang J, Gui F, He Z, Li L, Li Y, Li S, Wu X, Deng Z, Sun X, Huang X, Huang W, Han S, Zhang T, Wang Z, Jiao B, Song S, Wang H, Chen L, Zhou D, Liu Q, Ren R, Zhang J, Deng X. Jiang J, et al. Among authors: song s. Cancer Res. 2017 Jan 1;77(1):175-186. doi: 10.1158/0008-5472.CAN-16-1038. Epub 2016 Oct 10. Cancer Res. 2017. PMID: 27758886
44 results